These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16799799)

  • 1. Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?
    De Boeck K; De Baets F; Malfroot A; Desager K; Mouchet F; Proesmans M
    Eur J Pediatr; 2007 Jan; 166(1):23-8. PubMed ID: 16799799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.
    Burge PS; Calverley PM; Jones PW; Spencer S; Anderson JA; Maslen TK
    BMJ; 2000 May; 320(7245):1297-303. PubMed ID: 10807619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis.
    Balfour-Lynn IM; Klein NJ; Dinwiddie R
    Arch Dis Child; 1997 Aug; 77(2):124-30. PubMed ID: 9301350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis.
    Balfour-Lynn IM; Lees B; Hall P; Phillips G; Khan M; Flather M; Elborn JS;
    Am J Respir Crit Care Med; 2006 Jun; 173(12):1356-62. PubMed ID: 16556691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.
    Kemp JP; Osur S; Shrewsbury SB; Herje NE; Duke SP; Harding SM; Faulkner K; Crim CC
    Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
    Lumry WR; Conway MM; LaForce CF; Pearlman DS; Scott CA; Herje NE; Wu WW; Crim C
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):51-9. PubMed ID: 16440533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of fluticasone in acute symptomatic pulmonary sarcoidosis.
    Baughman RP; Iannuzzi MC; Lower EE; Moller DR; Balkissoon RC; Winget DB; Judson MA
    Sarcoidosis Vasc Diffuse Lung Dis; 2002 Oct; 19(3):198-204. PubMed ID: 12405489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.
    Dransfield MT; Bourbeau J; Jones PW; Hanania NA; Mahler DA; Vestbo J; Wachtel A; Martinez FJ; Barnhart F; Sanford L; Lettis S; Crim C; Calverley PM
    Lancet Respir Med; 2013 May; 1(3):210-23. PubMed ID: 24429127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children.
    Ducharme FM; Lemire C; Noya FJ; Davis GM; Alos N; Leblond H; Savdie C; Collet JP; Khomenko L; Rivard G; Platt RW
    N Engl J Med; 2009 Jan; 360(4):339-53. PubMed ID: 19164187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids for recurrent respiratory symptoms in preschool children in general practice: randomized controlled trial.
    Schokker S; Kooi EM; de Vries TW; Brand PL; Mulder PG; Duiverman EJ; van der Molen T
    Pulm Pharmacol Ther; 2008; 21(1):88-97. PubMed ID: 17350868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults.
    Rice-McDonald G; Bowler S; Staines G; Mitchell C
    Intern Med J; 2005 Dec; 35(12):693-8. PubMed ID: 16313543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.
    Dransfield MT; Feldman G; Korenblat P; LaForce CF; Locantore N; Pistolesi M; Watkins ML; Crim C; Martinez FJ
    Respir Med; 2014 Aug; 108(8):1171-9. PubMed ID: 24998880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report.
    Roorda RJ; Walhof CM
    Pediatr Pulmonol; 1998 Feb; 25(2):114-7. PubMed ID: 9516095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL; Baker JW; Kim KT; Blake KV; Scott CA; Wu W; Faris MA; Crim C
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short-term inhaled fluticasone on oxidative burst of sputum cells in cystic fibrosis patients.
    Dauletbaev N; Viel K; Behr J; Loitsch S; Buhl R; Wagner TO; Bargon J
    Eur Respir J; 1999 Nov; 14(5):1150-5. PubMed ID: 10596705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.